Daily as of 3 Nov 16:00 ET
- Price
- above both $2.44 vs 50 $1.87 / 200 $1.61
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 16 Oct 2026 · projected 27 bars out
PACB | Pacific Biosciences of CaliforniaNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$2.44
+$0.09 (+4.05%)
Pacific Biosciences of California (PACB) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat above the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits above the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $2.61 vs 50 $1.67 / 200 $4.20
- Projection
- 🟨Golden cross estimated 15+ weeks out
- Test
- No active test
- Last cross
- 💀Death cross week of 29 Aug 2022 · projected 30 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- above both $2.44 vs 50 $2.32 / 200 $1.63
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 28 Sep 2026 · projected 5 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 16 Oct 2026 | 🟨Golden moderate | daily | 27 bars out | Not tested |
| 28 Sep 2026 | 🟨Golden | 4-hour | 5 bars out | Not tested |
| 7 Aug 2026 | 💀Death | 4-hour | 19 bars out | Not tested |
| 2 Jul 2026 | 🟨Golden | 4-hour | 11 bars out | 1 bar cross test |
| 6 Apr 2026 | 💀Death steep | daily | 28 bars out | 3 bar cross test |
About PACB
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$11.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall